NLRP3 and carcinoma: At nine weeks, momordicoside G treatment resulted in not only mild lung tissue injury but also slight carcinoma lesions (Figure 3A,C) which were in line with the decreased M1-like macrophages (iNOS+ cells) (Figure 3B) and NLRP3 inflammasome (Figure 4A–C) and the increased levels of alveolar IL-10 and TGF-β1 (Figure 4D).